Buda Juice, Inc. (BUDA) AI Stock Analysis

Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages, citrus juices, and cold-pressed juices made from fruits and vegetables. Headquartered in Dallas, Texas, the company was incorporated in 2013 and serves wholesale clients. Operating in the non-alcoholic beverages industry, Buda Juice has 39 employees and completed its initial public offering in 2026 on the NYSE American exchange.

Annual revenue increased from $9.4M in FY2023 to $11.3M in FY2024, representing growth of 20.2%, and reached $12.6M in FY2025 with growth of 11.8%. This reflects a two-year revenue CAGR of 15.9% from FY2023 to FY2025. Gross margin was 40.5% in FY2023, 46.2% in FY2024, and 42.7% in FY2025. Operating margin shifted from 25.7% in FY2023 to 30.3% in FY2024 and 27.4% in FY2025. Net income was $2.3M in FY2023, $3.6M in FY2024, and $3.5M in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $14.1M with a net profit margin of 17.2% and EPS of $0.12. In the quarter ended June 30, 2026, quarterly revenue grew 26.4% year-over-year, while quarterly earnings fell 20.0%.

As of June 30, 2026, Buda Juice held $18.8M in cash and short-term investments compared to total debt of $717,000, yielding net cash of $18.1M. Shareholders' equity was $21.6M, supported by total assets of $23.8M. The company reported a current ratio of 15.21 and a debt-to-equity ratio of 0.03. In FY2025, operating cash flow was $3.1M and free cash flow was $2.9M. Cash use during FY2025 included capital expenditures of $246,000 and dividends paid of $3.0M.

At a last close of $7.50 on October 16, 2026, Buda Juice had a market cap of $94.2M and an enterprise value of $76.8M. The stock trades at a trailing P/E of 62.5x, well above the median of its US-listed Consumer Defensive peers of 18.6x. Its EV-to-EBITDA stands at 26.6x compared to the peer group median of 11.7x, and its price-to-sales ratio is 6.7x versus the peer median of 0.7x. The company trades between its 52-week low of $6.25 and 52-week high of $12.00, while the S&P 500 returned 16.8% over the past year.

Wall Street coverage shows a mean price target of $13.00, which is 73.3% above the last close of $7.50. For the current fiscal year ending December 31, 2026, analysts estimate EPS of $0.13, representing an earnings decline of 35.0%, and revenue of $17.1M. For the next fiscal year, 2 analysts project EPS to grow 50.0% to $0.20 on revenue of $20.8M, which implies revenue growth of 21.6%. The company's next earnings date is November 12, 2026.

This page is an AI-written research summary of Buda Juice, Inc. (BUDA). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BUDA income statement, BUDA balance sheet, BUDA key metrics, BUDA analyst forecast, BUDA chart. See the BUDA stock overview for the latest quote and news.